Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Equid Alphaherpesvirus 3 (EHV-3) Probe-based qPCR Kit

Product Overview

BioVenic Equid Alphaherpesvirus 3 (EHV-3) Probe-based qPCR Kit is designed for the real-time detection of Equid Alphaherpesvirus 3 (EHV-3) in biological samples using a probe-based qPCR method. For research use only.

Specifications

Assay Type Probe-based qPCR

Specificity Equid Alphaherpesvirus 3 (EHV-3)

Target Species Virus; Equine

Sample Requirement Biological samples

Target Information

Equine coital exanthema (ECE) is a highly contagious mucocutaneous disease transmitted venereally. It is characterized by the development of papules, vesicles, pustules, and ulcers on the external genitalia of mares and stallions, caused by equid alphaherpesvirus 3 (EHV-3). This infection is endemic worldwide, primarily spreading through direct contact during sexual intercourse and via contaminated instruments used in reproductive procedures at breeding facilities.

Target Equid Alphaherpesvirus 3 (EHV-3)

Target Synonym Equid Alphaherpesvirus 3; EHV-3; Equid herpesvirus 3; Equine coital exanthema virus; Equine herpesvirus 3

Taxonomy ID 80341

Shipping and Storage

This product is shipped with wet ice packs. Store at -20°C for 12 months. Avoid repeated freezing and thawing.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

Sample preparation (DNA isolation) is required before the assay procedure.

References

Vissani, María Aldana et al. "Equine Coital Exanthema: New Insights on the Knowledge and Leading Perspectives for Treatment and Prevention." Pathogens (Basel, Switzerland) vol. 10,8 1055. 20 Aug. 2021.